Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-05

Clinical Trial Update: A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants [Phase 2]

View source ↗

Summary

Phase 2 study comparing Armour Thyroid with levothyroxine in people with prior hypothyroidism, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Armour Thyroid (desiccated thyroid)
  • Levothyroxine (levothyroxine)

Snippet

Sponsor: Allergan | Conditions: Hypothyroidism, Thyroid Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-06-05